Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.21954
Abstract: Cancer stem cells (CSCs) are expanded in anaplastic thyroid cancer (ATC) and standard treatment approaches have failed to improve survival, suggesting a need to specifically target the CSC population. Recent studies in breast and colorectal… read more here.
Keywords: sumo inhibitors; sumo pathway; treatment; cancer ... See more keywords